BSFA
NEUTRALBSF Enterprise Announces Strategic Investment
The biotechnology company has conditionally placed new shares to bolster its strategic business and growth plans.
BSF Enterprise
3.1250GBX
-5.30%
Market Cap
4.08M
Volume
615.18k
77% of avg
P/E Ratio
EPS (TTM)
Beta
2.64
Day Range
2.7500p - 3.5000p
52 Week Range
1.2500p3.1250p6.4500p
3.1250p
Upcoming Events
Next 12 months
Joint development of cost-effective large-scale production of cells and tissues for 3DBT's lab-grown meat and leather products
High Impact Event
BSFA
NEUTRALBSF Enterprise PLC Announces Pioneering T-Rex Leather Joint Venture
The biotechnology company has partnered with a creative agency and a genomic engineering firm to produce sustainable luxury materials from prehistoric species, starting with T-Rex leather.
BSFA
GOODBSF Enterprise Accelerates Commercialization of Lab-Grown Leather Technology
The biotechnology company is accelerating the commercialization of its lab-grown leather technology, forming a subsidiary to drive the process and entering collaborations to validate market opportunities.
BSFA
NEUTRALBSF Enterprise PLC Announces 2025 AGM Details
The healthcare company has published details for its 2025 Annual General Meeting, including the date, location, and availability of related documents.
BSFA
NEUTRALBSF Enterprise Reports Annual Results: Progress Across Biotech Portfolio Despite Widening Losses
The biotechnology innovator reported progress across its portfolio, including advancements in lab-grown leather and corneal implants. Despite widening losses, the company secured additional funding and expanded into new markets.
BSFA
GOODBSF Enterprise Plc Announces Significant Operational Progress Across Subsidiaries
The healthcare company announces significant operational progress, including new product launches, successful collaborations, and strategic funding to support its growth initiatives.
BSFA
GOODBSF Enterprise Partners with Sartorius to Drive Sustainable Biotech Solutions
The biotechnology company has entered a strategic partnership with a global leader in bioprocess solutions to develop innovative and sustainable production methods for lab-grown meat and leather.
BSFA
GOOD3DBT Ltd Secures Prestigious Northern Accelerator Grant to Advance Lab-Grown Leather Technology
Biotech company secures grant to advance its innovative lab-grown leather technology, positioning it for future growth.
BSFA
NEUTRALBSF Enterprise Secures £500,000 in Oversubscribed Placing
Biotech innovator boosts growth plans
BSFA
GOODBSF Enterprise Advances Cell-Based Technologies Across Portfolio
Innovative biotech company BSF Enterprise reports progress in cell-based technologies across its portfolio, including leather, tissue engineering, and cultivated meat.